Recombinant Xenopus laevis Forkhead box protein N2 (foxn2)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Xenopus laevis Forkhead Box Protein N2 (foxn2)

Recombinant Xenopus laevis Forkhead box protein N2 (foxn2) is a recombinant protein derived from the African clawed frog, Xenopus laevis. This protein belongs to the Forkhead box family, which is a group of transcription factors known for their role in regulating various cellular processes, including development, differentiation, and immune responses. The foxn2 gene is part of this family and has been studied for its potential applications in molecular biology and biotechnology.

Characteristics and Production of Recombinant Xenopus laevis Forkhead Box Protein N2 (foxn2)

  • Production Hosts: Recombinant Xenopus laevis Forkhead box protein N2 (foxn2) can be produced in various hosts such as E. coli, yeast, baculovirus, or mammalian cells. The choice of host depends on the desired level of protein modification and the intended application of the protein .

  • Purity and Yield: The purity of the recombinant protein is typically greater than or equal to 85%, as determined by SDS-PAGE, indicating a high level of purification .

Table: Characteristics of Recombinant Xenopus laevis Forkhead Box Protein N2 (foxn2)

CharacteristicDescription
HostsE. coli, Yeast, Baculovirus, Mammalian Cells
Purity≥ 85% (SDS-PAGE)
ApplicationsMolecular Biology, Biotechnology

Table: Comparison with Other Forkhead Proteins

ProteinSpeciesFunction
FoxPLitopenaeus vannameiImmune Response Regulation
FoxH1ZebrafishEmbryonic Development
FoxN3VariousDNA Binding Specificity

References Cdc2p controls the forkhead transcription factor... - EMBO Press Foxn2 - Search Results - MyBioSource A Novel Forkhead Box Protein P (FoxP) From Litopenaeus vannamei Plays a Positive Role in Immune Response Molecular basis for DNA recognition by the maternal pioneer... The Fox gene family in Xenopus laevis:FoxI2, FoxM1 and... - PubMed Conservation and diversity of Foxp2 expression in muroid rodents: Functional implications Bispecific Forkhead transcription factor FoxN3 recognizes two...

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If a particular tag type is required, please specify it in your order for preferential development.
Synonyms
foxn2Forkhead box protein N2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-430
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Xenopus laevis (African clawed frog)
Target Names
foxn2
Target Protein Sequence
MGPATGMTPD KNIESPTAEK VPGLSQTENM GSLPEEVGAA RPKASMVDNG ATDEELTNLN WLHESTNLLN NFSLGSEGVS AGSPLYDIEG DLSPSGCQTP EKLSASSKPP YSFSLLIYMA IEHSPNKCLP VKDIYSWILD RFPYFSTAPT GWKNSVRHNL SLNKYFQKVE RSHGKVNGKG SLWCVDPEYK PSLIQALKKQ PFSSALALYT PPTSPTSVSS RPYVLTSASR RKQIHYVKDS DIDAATAMML LNSSIKEEAL DRQKPQPLKV VLPKKRSYAS AFKHCPPLSL QENDGEVINI DPKEDHNYSA SGGDSQRCES RSSVSSLSSV EEVYEFIPKN SRTGSDGSEG FHSEDDTDID YEEDTLGDNG YVPQPSGNDL HGSKLRKEAS QDIDEELKEA AGSLLHLAGI RTCLDSLLKT AKAQSHKHRK
Uniprot No.

Target Background

Database Links

KEGG: xla:447464

UniGene: Xl.80045

Subcellular Location
Nucleus.
Tissue Specificity
Expressed in the developing eye from stage 23. Localized to the prospective retinal layer and a layer of cells lateral to the ventricular zone. At stage 29, expression extends to the branchial arches and the brain. At stage 33/34, expressed in the vagal g

Q&A

How does Xenopus laevis genome structure impact FoxN2 research?

Xenopus laevis possesses an allotetraploid genome resulting from a whole genome fusion approximately 17-18 million years ago. Consequently, most genes have two homeologs, typically labeled L (Long Chromosome) and S (Short Chromosome) . The FoxN2 gene exists as two homeologs: foxn2.L and foxn2.S.
This genomic structure creates unique considerations for researchers:

  • Expression data must account for both homeologs, which may have different expression patterns or levels

  • Genetic manipulations must consider potential functional redundancy between homeologs

  • Primer and probe design must distinguish between highly similar homeologs

  • Analysis should consider the combined expression of both homeologs when comparing to orthologous genes in other species
    For FoxN2 specifically, the S homeolog transcript has been identified as: "XM_018264497.1|foxn2.S|Xenopus laevis forkhead box N2 S homeolog (foxn2.S), transcript variant X1, mRNA" .

How does FoxN2 compare to other Fox family members in Xenopus laevis?

Fox family proteins in Xenopus laevis have diverse expression patterns and developmental roles:

Fox ProteinExpression PatternDevelopmental Role
FoxI2Maternal transcription; zygotic transcripts first detected during neurulationLocalizes to dorsal part of epibranchial placodes
FoxM1Maternal expression; found in animal blastomeres during early cleavage; strongly upregulated during neurula stagesExpressed in neuroectoderm, spinal cord, rhombencephalon, retina, and branchial arches
FoxP1Maternal expression; found in animal blastomeres during early cleavageExpressed in brain, head mesenchyme, and splanchnic layer of lateral plate mesoderm
FoxH1Maternal pioneer factorBinds to specific GG/GT-containing DNA target sequences; levels increase during stages 8-9 and decrease at stage 10.5
FoxN3Not specified in search resultsRequired for craniofacial and eye development; knockdown affects jaw cartilage, cranial nerves, and eye size
While specific FoxN2 expression data is limited in the provided search results, its function likely relates to transcriptional regulation during development, similar to other Fox family members.

What are the binding properties of FoxN2 compared to other Fox family proteins?

While FoxN2-specific binding data is limited, insights can be drawn from related Fox proteins. FoxH1 binding properties reveal important characteristics of Fox family DNA interactions:
FoxH1 binds to specific GG/GT-containing DNA targets, with protein-DNA interactions extending to both minor and major DNA grooves. These interactions are almost twice as extensive as those of other FOX family members . FoxH1 contains specific amino acid changes allowing recognition of GG/GT motifs, and its affinity for nucleosomal DNA is even higher than for linear DNA fragments .
For FoxN2 research, consider these binding properties:

  • FoxN2 likely has sequence-specific DNA binding preferences

  • Binding may involve interactions with both minor and major DNA grooves

  • The extended forkhead domain (beyond the canonical ~100 residues) may be critical for full binding activity

  • FoxN2 binding might be affected by chromatin structure
    Experimental approaches to determine FoxN2 binding should include:

  • Differential scanning fluorimetry with various DNA motifs

  • Native gel electrophoresis with labeled DNA fragments

  • Competition assays between FoxN2 and other Fox proteins

  • ChIP-seq analysis during different developmental stages

How can I design experiments to investigate FoxN2 function in Xenopus laevis development?

Designing robust experiments to investigate FoxN2 function requires considering the unique advantages of Xenopus laevis as a model system:
Functional Knockdown Approaches:

  • Morpholino antisense oligonucleotides targeting both foxn2.L and foxn2.S homeologs

  • CRISPR/Cas9-mediated knockout of foxn2 genes

  • Dominant-negative constructs expressing truncated FoxN2 protein
    Expression Analysis Methods:

  • In situ hybridization to map spatial expression patterns during development

  • RT-qPCR to quantify temporal expression of foxn2 homeologs

  • Single-cell RNA sequencing to identify cell types expressing foxn2
    Functional Rescue Experiments:

  • Microinjection of foxn2 mRNA to rescue knockdown phenotypes

  • Domain-specific mutations to identify critical regions for FoxN2 function

  • Heterologous rescue with orthologs from other species
    Xenopus laevis offers specific advantages for these experiments:

  • External fertilization and development allow easy manipulation of embryos

  • Large embryo size facilitates microinjection and tissue isolation

  • Rapid development enables quick assessment of phenotypes

  • Embryos can be obtained in large numbers for statistical significance

  • Neural tube explants and animal cap assays provide simplified experimental systems

What are the potential protein interaction partners of FoxN2 and how might they influence its function?

Based on studies of related Fox proteins, FoxN2 likely interacts with various cofactors to regulate gene expression. For example, FoxN3 interacts with components of histone deacetylase complexes (HDAC), including xSin3 and xRPD3, suggesting a role in chromatin remodeling .
Potential approaches to identify FoxN2 interaction partners include:

  • GST-pulldown assays: Express GST-tagged FoxN2 and use it to pull down interacting proteins from Xenopus embryo lysates.

  • Co-immunoprecipitation: Use anti-FoxN2 antibodies to precipitate FoxN2 along with its binding partners from embryonic extracts.

  • Yeast two-hybrid screening: Identify potential binding partners using FoxN2 as bait against a Xenopus cDNA library.

  • Proximity labeling approaches: Express BioID or APEX2 fusion proteins to identify proteins in close proximity to FoxN2 in living cells.

  • Mass spectrometry: Analyze immunoprecipitated complexes to identify FoxN2-associated proteins.
    Predicted interaction partners may include:

  • Components of chromatin remodeling complexes

  • Other transcription factors, particularly those active during similar developmental stages

  • Proteins involved in RNA polymerase II recruitment

  • Cell signaling pathway components that might regulate FoxN2 activity

What are the optimal expression and purification methods for recombinant Xenopus laevis FoxN2?

The production of high-quality recombinant Xenopus laevis FoxN2 requires careful consideration of expression systems and purification strategies:
Expression Systems:

  • E. coli: Most commonly used for Fox proteins. For FoxN2, consider using BL21(DE3) or Rosetta strains with pET or pGEX vectors for GST-fusion proteins.

  • Insect cells: Baculovirus expression systems may provide better folding for full-length FoxN2.

  • Mammalian cells: HEK293T cells can express FoxN2 with proper post-translational modifications.
    Construct Design Considerations:

  • Extended FoxH1 constructs (~140-180 residues) show greater stability and DNA binding compared to canonical domains (~100 residues) , suggesting FoxN2 constructs should include regions extending beyond the core forkhead domain.

  • Consider expressing different domains: N-terminal region, forkhead domain, and C-terminal region.

  • Include purification tags (His6, GST) with TEV or PreScission protease cleavage sites.
    Purification Protocol:

  • Affinity chromatography (Ni-NTA for His-tagged or glutathione-agarose for GST-tagged proteins)

  • Ion exchange chromatography to remove nucleic acid contamination

  • Size exclusion chromatography to obtain homogeneous protein

  • Assess purity by SDS-PAGE (target ≥85% purity)

  • Verify protein identity by mass spectrometry and/or western blotting
    Protein Stability Assessment:

  • Verify protein folding by circular dichroism

  • Assess thermal stability using differential scanning fluorimetry

  • Test DNA binding activity using electrophoretic mobility shift assays

How can I effectively use microinjection techniques for FoxN2 studies in Xenopus laevis embryos?

Microinjection is a powerful technique for manipulating gene expression in Xenopus laevis embryos:
Preparation of Embryos:

  • Obtain embryos through in vitro fertilization using standard protocols.

  • Dejelly fertilized eggs in 2% cysteine solution (pH 8) in 1/3× modified Barth's solution (MBS).

  • Transfer embryos to MBS supplemented with 4% Ficoll-400 for microinjection .
    Injection Solutions for FoxN2 Studies:

  • mRNA overexpression: Capped foxn2 mRNA (250 pg) synthesized using mMessage mMachine kit.

  • Morpholino knockdown: Antisense morpholinos (10-20 ng) targeting foxn2.L and foxn2.S.

  • CRISPR/Cas9: Cas9 mRNA (500 pg) with sgRNAs (200 pg) targeting foxn2 genes.

  • Reporter constructs: FoxN2-responsive promoter driving fluorescent reporter genes.
    Injection Procedure:

  • Prepare microinjection needles with 10-20 μm tip diameter.

  • Calibrate injection volume to deliver 5-10 nl per injection.

  • Add phenol red (0.05%) to injection solution as a tracer.

  • For targeting specific tissues, inject at one-cell stage (for whole embryo) or at later stages into specific blastomeres based on fate mapping.

  • After injection, transfer embryos to 1/3× MBS with antibiotics (100 units/ml penicillin, 0.1 mg/ml streptomycin, 0.25 μg/ml amphotericin B) .
    Advantages of Xenopus laevis for Microinjection:

  • Large embryo size facilitates precise injections

  • Rapid development allows quick assessment of phenotypes

  • External development enables continuous observation

  • Ability to target specific tissues through targeted injections at later stages

What techniques are most effective for analyzing FoxN2 expression patterns in Xenopus laevis?

Multiple complementary approaches can effectively analyze FoxN2 expression patterns:
RNA-based Methods:

  • In situ hybridization to visualize spatial expression:

    • Design probes specific to foxn2.L and foxn2.S homeologs

    • Use digoxigenin-labeled antisense RNA probes

    • Follow established protocols for Xenopus embryos

    • Consider double fluorescent in situ hybridization to compare with other genes

  • RT-qPCR for quantitative temporal expression analysis:

    • Design primers specific to each homeolog

    • Use stage-specific embryo collections (from early cleavage to tadpole stages)

    • Normalize to appropriate reference genes (e.g., ornithine decarboxylase)

    • Present data as relative expression across developmental stages

  • RNA sequencing:

    • For genome-wide context of foxn2 expression

    • Consider developmental time-course experiments

    • Single-cell RNA-seq to identify cell types expressing foxn2

    • Compare expression between foxn2.L and foxn2.S homeologs
      Protein-based Methods:

  • Immunohistochemistry/Immunofluorescence:

    • Use validated antibodies against FoxN2

    • Consider antibodies that recognize both homeologs

    • Counterstain with markers for specific cell types or structures

  • Western blotting:

    • Prepare protein extracts from different developmental stages

    • Use tissues dissected from specific regions for spatial analysis

    • Compare protein levels with mRNA expression data

  • ChIP-seq to identify genome-wide binding sites:

    • Use anti-FoxN2 antibodies or tagged recombinant proteins

    • Compare with binding patterns of other Fox family members

    • Analyze motifs enriched at binding sites
      By combining these techniques, researchers can build a comprehensive profile of FoxN2 expression and function throughout Xenopus laevis development.

How can I integrate data from Xenopus laevis FoxN2 studies with information from other model organisms?

Integrating FoxN2 data across species requires careful consideration of evolutionary relationships and genomic differences:
Comparative Genomic Approaches:

  • Align FoxN2 protein sequences from multiple species to identify:

    • Conserved domains likely critical for function

    • Species-specific regions that may confer unique properties

    • Conservation of DNA-binding domains and specificity determinants

  • Compare synteny around foxn2 loci to identify:

    • Conserved gene neighborhoods that might share regulatory mechanisms

    • Genomic rearrangements that could affect expression patterns
      Cross-species Functional Analysis:

  • Test functional conservation through rescue experiments:

    • Can human FOXN2 rescue Xenopus foxn2 knockdown phenotypes?

    • Can Xenopus foxn2 rescue phenotypes in zebrafish or mouse models?

  • Compare binding specificities:

    • Do FoxN2 proteins from different species recognize similar DNA motifs?

    • Are there species-specific differences in cofactor interactions?
      Data Integration Strategies:

  • Create unified gene expression databases by normalizing data across species

  • Use orthology mapping tools to compare expression patterns across model organisms

  • Develop pathway models incorporating FoxN2 function based on multi-species data
    Specific Considerations for Xenopus laevis:

  • Account for homeolog-specific data when comparing to diploid organisms

  • Consider that Xenopus laevis and Xenopus tropicalis diverged 30-90 million years ago

  • Note that despite 90% identity in coding regions, there may be significant differences in gene regulation

  • Recognize that different developmental rates and environmental preferences between species may influence experimental outcomes

How can I address inconsistent results when studying FoxN2 in Xenopus laevis?

Inconsistent results in FoxN2 research may stem from several sources that require systematic troubleshooting:
Common Sources of Variability and Solutions:

  • Homeolog-specific effects:

    • Design experiments to distinguish between foxn2.L and foxn2.S

    • Use homeolog-specific morpholinos or CRISPR targeting

    • Analyze expression of each homeolog separately before combining data

  • Developmental timing variations:

    • Standardize developmental staging using Nieuwkoop and Faber criteria

    • Account for temperature effects on developmental rate

    • Document exact timing of observations and manipulations

  • Maternal vs. zygotic contributions:

    • Distinguish between maternal and zygotic transcripts

    • Consider maternal depletion approaches for maternal transcripts

    • Design experiments to target specific temporal windows

  • Technical considerations:

    • Validate antibody specificity for Xenopus FoxN2

    • Ensure morpholino efficacy through western blotting

    • Verify CRISPR targeting through sequencing
      Recommended Approach for Resolving Inconsistencies:

  • Systematically document experimental conditions

  • Perform biological replicates with embryos from different parents

  • Include appropriate positive and negative controls

  • Validate key findings using complementary techniques

  • Consider temperature sensitivity of phenotypes (Xenopus tropicalis develops at higher temperatures than Xenopus laevis)

What statistical approaches are recommended for analyzing FoxN2 expression and function data?

  • Temporal expression profiles:

    • Use time-series analysis methods

    • ANOVA with post-hoc tests for comparing stages

    • Consider mixed-effects models for incorporating biological variation

  • Spatial expression comparisons:

    • Quantitative image analysis with appropriate controls

    • Consider tissue-specific normalization approaches

    • Use non-parametric tests if assumptions of normality are not met
      For Functional Studies:

  • Phenotypic analysis:

    • Calculate penetrance and expressivity of phenotypes

    • Use appropriate sample sizes (n≥30 embryos per condition, across multiple clutches)

    • Consider blind scoring of phenotypes to avoid bias

  • Rescue experiments:

    • Quantify degree of rescue using objective metrics

    • Use dose-response analysis for rescue constructs

    • Apply ANOVA with planned comparisons
      Data Visualization Recommendations:

  • Collect expression data across multiple biological replicates

  • Test for normality using Shapiro-Wilk test

  • Apply log transformation if necessary

  • Perform one-way ANOVA if parametric assumptions are met

  • Apply Tukey's HSD for post-hoc comparisons

  • Report p-values with appropriate corrections for multiple testing

What emerging technologies could advance our understanding of FoxN2 function in Xenopus laevis?

Several cutting-edge technologies offer promising avenues for FoxN2 research:
Genome Editing and Genetic Manipulation:

  • Prime editing for precise genomic modifications of foxn2 loci

  • Optogenetic control of FoxN2 activity to manipulate function with spatial and temporal precision

  • Expanding the genetic code of Xenopus laevis to incorporate unnatural amino acids into FoxN2 for novel functional studies

  • CRISPRa/CRISPRi for targeted activation or repression of foxn2 expression
    Advanced Imaging Approaches:

  • Light sheet microscopy for long-term live imaging of FoxN2 reporter lines

  • Super-resolution microscopy to visualize FoxN2 interactions in the nucleus

  • Micro-CT imaging for non-invasive 3D visualization of developmental phenotypes

  • Spatial transcriptomics to map foxn2 expression within tissue contexts
    Single-cell and Multi-omics Approaches:

  • Single-cell RNA-seq to identify cell populations expressing foxn2

  • Single-cell ATAC-seq to correlate chromatin accessibility with foxn2 expression

  • CUT&Tag or CUT&RUN for high-resolution mapping of FoxN2 binding sites

  • Proteomics approaches to identify stage-specific FoxN2 interaction partners
    In vitro Systems:

  • Organoid cultures derived from Xenopus tissues for extended manipulation

  • Cell-free expression systems to study FoxN2 biochemistry

  • Reconstituted chromatin systems to study FoxN2 pioneering activity

What are the most significant unanswered questions regarding FoxN2 in developmental biology?

Despite advances in Fox protein research, several fundamental questions about FoxN2 remain unanswered:

  • Developmental Role: What are the specific developmental processes regulated by FoxN2 in Xenopus laevis, and how do they compare to FoxN2 functions in other vertebrates?

  • Homeolog Specialization: Have the foxn2.L and foxn2.S homeologs undergone subfunctionalization or neofunctionalization since the genome duplication event in Xenopus laevis?

  • DNA Binding Specificity: What are the precise DNA motifs recognized by FoxN2, and how do they differ from those bound by other Fox family members?

  • Regulatory Networks: What genes are directly regulated by FoxN2, and what upstream factors control foxn2 expression during development?

  • Molecular Evolution: How has FoxN2 function evolved across vertebrate lineages, and what domains are responsible for species-specific functions?

  • Epigenetic Regulation: Does FoxN2 function as a pioneer factor like FoxH1, capable of binding condensed chromatin and facilitating subsequent transcription factor binding?

  • Disease Relevance: What human developmental disorders or diseases might be linked to FoxN2 dysfunction, and can Xenopus models provide insights into these conditions?

  • Interaction with Signaling Pathways: How does FoxN2 integrate with major developmental signaling pathways like FGF, TGF-beta, MAPK, Retinoic acid, Wnt, and Hedgehog signaling ? Addressing these questions will significantly advance our understanding of vertebrate development and the specific contributions of FoxN2 to this process.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.